Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Inspection Questions Delay CBER’s Embrace Of Real-Time Oncology Review
Apr 07 2021
•
By
Derrick Gingery
The complex biologic manufacturing process could limit the applicability of real-time review. • Source: Shutterstock
More from Review Pathways
More from Pathways & Standards